Extensively Drug-Resistant TB in Eastern Cape, South Africa: High Mortality in HIV-Negative and HIV-Positive Patients
Authors:
- Charlotte L KvasnovskyCKCharlotte L Kvasnovsky
- J Peter CegielskiJCJ Peter Cegielski
- Roshen ErasmusRERoshen Erasmus
- N Olga SiwisaNSN Olga Siwisa
- Khulile ThomasKTKhulile Thomas
- Martie L van der WaltMWMartie L van der Walt
- 1 June 2011
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 57 (2) , 146-152
Abstract
Tuberculosis is a leading cause of morbidity and mortality worldwide. Patients with extensively drug-resistant tuberculosis (XDR-TB) have had high mortality rates, especially when coinfected with HIV. A retrospective cohort study of the first 206 patients treated for XDR-TB in Eastern Cape Province, South Africa, October 2006 to January 2008, a province that has treated multidrug-resistant tuberculosis since 2000. All 206 patients were hospitalized for treatment until monthly sputum specimens were culture negative. Sixty-five patients diagnosed with XDR-TB died before XDR-TB treatment start. Among 195 patients starting treatment with a known HIV status, 108 (55.4%) were HIV positive, and 86 patients (44.1%) died during the first year of treatment. HIV-positive patients receiving antiretroviral treatment (ARVs) fared and HIV-negative patients, and more of both these groups survived than HIV-positive patients not on ARVs. However, HIV-negative patients experienced more serious adverse events requiring the withdrawal of medications than did HIV-positive patients, regardless of the use of ARVs. Experience in Eastern Cape Province, South Africa, suggests that patients can be treated for both XDR-TB and HIV. We have also shown that such combination therapy can be well tolerated by patients.Keywords
This publication has 12 references indexed in Scilit:
- Epidemiology of antituberculosis drug resistance 2002–07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance SurveillanceThe Lancet, 2009
- Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007JAMA, 2008
- Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort studyThe Lancet, 2008
- Comprehensive Treatment of Extensively Drug-Resistant TuberculosisNew England Journal of Medicine, 2008
- High rate of extensively drug-resistant tuberculosis in Indian AIDS patientsAIDS, 2007
- HIV Infection and Multidrug‐Resistant Tuberculosis—The Perfect StormThe Journal of Infectious Diseases, 2007
- Surgery for patients with drug-resistant tuberculosis: report of 121 cases receiving community-based treatment in Lima, PeruThorax, 2007
- Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South AfricaThe Lancet, 2006
- Lack of Weight Gain and Relapse Risk in a Large Tuberculosis Treatment TrialAmerican Journal of Respiratory and Critical Care Medicine, 2006
- The Emergence of Drug-Resistant Tuberculosis in New York CityNew England Journal of Medicine, 1993